BBJP vs PGJ
JPMorgan BetaBuilders Japan ETF against Invesco Golden Dragon China ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
0%
0 shared positions
Fee gap
51 bp
BBJP is cheaper
1-year return gap
50.6 pts
BBJP is ahead
Larger fund
BBJP
$19.7B
Side by side
| BBJP | PGJ | |
|---|---|---|
| Fund | JPMorgan BetaBuilders Japan ETF | Invesco Golden Dragon China ETF |
| Issuer | JPMorgan | Invesco |
| Category | Single Country | Single Country |
| Expense ratio | 0.19% | 0.70% |
| Assets | $19.7B | $85M |
| Average daily dollar volume | $96M | $453K |
| Listed | Jun 15, 2018 | Dec 9, 2004 |
| FrenzyCap score | 93 | 20 |
| 1-month return | +1.4% | −0.9% |
| 3-month return | +5.4% | −6.1% |
| Year to date | +19.7% | −23.0% |
| 1-year return | +16.8% | −33.8% |
| 30-day volatility | 16.9% | 18.3% |
| Worst drawdown, 1 year | −13.6% | −35.3% |
| Trailing 12-month yield | 4.48% | 1.94% |
| Holdings | 182 | 68 |
| Top 10 weight | 27.6% | 12.6% |
| Look-through P/E | — | 14.5 |
| Holdings vs fair value | — | +47.3% |
| Holdings above 200-day average | — | 0% |
| Net flow, latest 3 reported months | +$988M thru Jul 2026 | −$11M thru Jul 2026 |
| 30-day implied volatility | 23.2% | 31.7% |
| Holdings as of | as of Apr 30, 2026SEC filing | as of Oct 8, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
0% of BBJP · 0% of PGJNo holdings in common.
Sector mix of the stock holdings
| Sector | BBJP | PGJ | Gap |
|---|---|---|---|
| Consumer Discretionary | 0.0% | 8.3% | −8.3% |
| Financials | 0.0% | 3.7% | −3.7% |
| Technology | 0.0% | 0.6% | −0.6% |
| Materials | 0.0% | 0.1% | −0.1% |
More: full overlap table · BBJP holdings · PGJ holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.